Tumour Virology, Immunology and Cellular Pathology

The Tumour Virology Laboratory has a strong interest in understanding how HPV enters the target cell. Current studies are focused on understanding how a viral capsid protein, L2, directs the incoming viral genome to the nucleus. In particular, we are interested in how this protein recruits the cellular machinery involved in the regulation of endocytic cargo transport, and ensures the correct trafficking of the incoming viral genome.

    Related Conference of Tumour Virology, Immunology and Cellular Pathology

    November 22-23, 2024

    5th Global Summit on Public Health

    Paris, France
    November 25-26, 2024

    10th World Holistic Nursing Conference

    Bali, Indonesia
    January 27-28, 2025

    10th World Congress on Public Health and Nutrition

    Bangkok, Thailand
    February 24-25, 2025

    21st Global Congress on Healthcare and Technologies

    Madrid, Spain
    March 17-18, 2025

    5th International conference on Healthcare Summit

    Singapore City, Singapore
    March 27-28, 2025

    7th International Conference on Digital Health

    London, UK
    April 07-08, 2025

    7th World Summit on Women's Health and Cancer Awareness

    Vancouver, Canada
    April 24-25, 2025

    4th International Congress on Global Healthcare

    Vienna, Austria
    May 14-15, 2025

    7th World Conference on Vaccine and Immunology

    Barcelona, Spain
    May 22-23, 2025

    International Congress on Primary Health and Safety

    Toronto, Canada
    July 23-24, 2025

    30th International Conference on Skincare and Cosmetology

    Amsterdam, Netherlands
    July 24-25, 2025

    36th European Heart and Heart Failure Congress

    Paris, France
    September 22-23, 2025

    21st Global Biomarkers and Clinical Research Summit

    Paris, France

    Tumour Virology, Immunology and Cellular Pathology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in